Clínica Baviera, S.A. (BME:CBAV)

Clínica Baviera Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	10.19	5.59	10.14	8.31	19.17	9.8
Short-Term Investments	41.41	44.73	27.59	41.46	19.29	22.47
Cash & Short-Term Investments	51.59	50.32	37.73	49.77	38.46	32.27
Cash Growth	30.42%	33.37%	-24.18%	29.39%	19.18%	19.81%
Accounts Receivable	5.1	4.64	4.02	2.95	2.84	3.36
Other Receivables	0.51	0.1	0.69	0.61	0.31	0.08
Receivables	5.61	4.73	4.71	3.56	3.15	3.45
Inventory	3.76	3.32	3.28	2.47	2.16	1.93
Other Current Assets	1.66	0.96	2	1.94	0.83	0.27
Total Current Assets	62.62	59.34	47.72	57.74	44.61	37.92
Property, Plant & Equipment	145.26	143.14	122.66	99.06	86.08	77.25
Long-Term Investments	0.1	0.1	0.06	0.09	0.12	0.19
Goodwill	29.01	29.01	29.01	14.62	14.62	14.62
Other Intangible Assets	12.12	11.08	8.73	2.75	0.46	1
Long-Term Deferred Tax Assets	3.26	3.16	1.88	1.4	1.01	0.98
Other Long-Term Assets	2.47	1.61	2.2	2.81	3.03	1.65
Total Assets	254.84	247.51	212.39	178.64	150.1	133.81

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	11.21	21.45	17.17	15.52	15.62	12.98
Accrued Expenses	-	15.34	12.99	10.75	8.46	7.71
Current Portion of Long-Term Debt	2.58	2.04	1.91	2.02	2.01	4.1
Current Portion of Leases	-	11.1	9.32	8.64	7.83	7.46
Current Income Taxes Payable	8.59	3.97	3.61	3.48	1.95	2.92
Other Current Liabilities	44.27	7.57	5.44	4.85	5.17	0.69
Total Current Liabilities	66.65	61.47	50.44	45.27	41.04	35.87
Long-Term Debt	7.32	5.89	5.29	0.5	2.52	6.47
Long-Term Leases	61.52	50.13	44.82	36.11	35.41	33.37
Long-Term Deferred Tax Liabilities	1.38	1.61	1.61	0.51	0.26	0.29
Other Long-Term Liabilities	5.76	17.46	11.88	3.97	2.51	2.42
Total Liabilities	142.64	136.55	114.03	86.37	81.74	78.42

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	1.63	1.63	1.63	1.63	1.63	1.63
Additional Paid-In Capital	4.89	4.89	4.89	4.89	4.89	4.89
Retained Earnings	26.21	42.39	40.53	36.3	21.69	19.56
Treasury Stock	-8.11	-8.42	-9.14	-0.11	-0.09	-0.08
Comprehensive Income & Other	86.94	69.5	59	48.28	39.22	28.59
Total Common Equity	111.57	109.99	96.92	91	67.34	54.6
Minority Interest	0.64	0.97	1.44	1.28	1.02	0.79
Shareholders' Equity	112.21	110.96	98.36	92.28	68.37	55.39
Total Liabilities & Equity	254.84	247.51	212.39	178.64	150.1	133.81

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	71.42	69.16	61.33	47.27	47.77	51.4
Net Cash (Debt)	-19.82	-18.84	-23.6	2.49	-9.31	-19.13
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-1.24	-1.18	-1.48	0.15	-0.57	-1.17
Filing Date Shares Outstanding	16.03	16.02	15.99	16.3	16.3	16.3
Total Common Shares Outstanding	16.03	16.02	15.99	16.3	16.3	16.3
Working Capital	-4.03	-2.13	-2.72	12.48	3.57	2.06
Book Value Per Share	6.96	6.87	6.06	5.58	4.13	3.35
Tangible Book Value	70.44	69.89	59.18	73.63	52.27	38.99
Tangible Book Value Per Share	4.39	4.36	3.70	4.52	3.21	2.39
Land	-	134.63	121.66	107.33	98.87	90.13
Machinery	-	154.15	134.47	113.73	91.42	94.17
Construction In Progress	-	2.79	0.38	6.37	5	-

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 25, 2026

Data Sources Report a data error